A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 14,274 shares of HUMA stock, worth $16,843. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,274
Previous 14,235 0.27%
Holding current value
$16,843
Previous $29,000 17.24%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 31, 2025

BUY
$1.41 - $2.73 $54 - $106
39 Added 0.27%
14,274 $24,000
Q2 2025

Jul 25, 2025

BUY
$1.15 - $2.77 $16,370 - $39,430
14,235 New
14,235 $29,000

Others Institutions Holding HUMA

About Humacyte, Inc.


  • Ticker HUMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,007,000
  • Market Cap $122M
  • Description
  • Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...
More about HUMA
Track This Portfolio

Track Vanguard Personalized Indexing Management, LLC Portfolio

Follow Vanguard Personalized Indexing Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.